comparemela.com

Latest Breaking News On - Insilicotrials - Page 1 : comparemela.com

FDA Purchases XPS license - Developed by RCPE and Distributed by InSilicoTrials

/PRNewswire/ The Research Center Pharmaceutical Engineering (RCPE) and InSilicoTrials are pleased to announce a significant milestone in their collaborative.

United statesCompetence centers for excellent technologiesDrug administrationResearch center pharmaceutical engineeringUnited states foodXtended particle simulationsDiscrete element methodGraphics processing unitsResidence time distributionsExcellent technologiesLand steiermark

Mark Lovern Joins InSilicoTrials as Chief Platform Officer

/PRNewswire/ Today, InSilicoTrials warmly welcomes Dr. Mark Lovern in his new role as Chief Platform Officer, a move marking the company s continued.

Mark lovernChief platform officerArtificial intelligenceMachine learningLuca emili

InSilicoTrials and AchilleS Vaccines Join Forces to Create Next-Generation Vaccines and Monoclonal Antibodies against Infectious Diseases

MILAN, April 21, 2023 /PRNewswire/ InSilicoTrials and AchilleS Vaccines have announced a strategic alliance that aims to unite visions, skills, experiences, the multidisciplinary collaboration

Riccardo baccheschiPrnewswire insilicotrialsAchilles vaccinesEuropean commissionAchilles vaccineInsilicovaccine suiteOuter membrane vesiclesImmunogenicity risk screenLuca emiliInsilico trialsSilico world

RCPE and InSilicoTrials add new tool to their XPS simulation software

/PRNewswire/ RCPE and InSilicoTrials agreed to an exclusive partnership to commercialize the XPS simulation software in May 2022. Today the two companies.

University of grazGraz university of techJoanneum research gmbResearch center pharmaceutical engineeringGraz universityJoanneum research gmbh

InSilicoTrials research paper published in the Special Issue Modeling for Advancing Regulatory Science by Annals of Biomedical Engineering (ABME)

/PRNewswire/ InSilicoTrials, leading player in using artificial intelligence (AI) and Modeling & Simulation (M&S) for drug and medical device development,.

Tinam morrisonPrnewswire insilicotrialsJoe bidenInnovation for advancing public healthEuropean commissionBiomedical engineering societyAccelerating digitalizationInsilicotrials cloud based platformFour use casesSpecial issueAdvancing regulatoryBiomedical engineeringRegulatory scienceAdvancing publicComputer modelingLuca emili

vimarsana © 2020. All Rights Reserved.